Skip to main content
. Author manuscript; available in PMC: 2015 Apr 10.
Published in final edited form as: Int J Pharm. 2014 Jan 17;464(0):178–184. doi: 10.1016/j.ijpharm.2014.01.009

Figure 5.

Figure 5

Comparison of cell death of SK-OV-3TR cells after the treatment with various concentrations of PCL, 10 µM CUR, or combination treatment. MDR reversal capability of CUR was best demonstrated at a concentration of 10 µM. Cell viability was determined using CellTiter Blue cell viability assay. Data shown are representative of 3 independent experiments and each performed in triplicate.